Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 306

1.

An Overview of Machine Learning and Big Data for Drug Toxicity Evaluation.

Vo AH, Van Vleet TR, Gupta RR, Liguori M, Rao MS.

Chem Res Toxicol. 2019 Oct 18. doi: 10.1021/acs.chemrestox.9b00227. [Epub ahead of print]

PMID:
31625725
2.

Minimally Invasive Mitral Valve Surgery for Rheumatic Valve Disease.

Vo AT, Le KM, Nguyen TT, Vu TT, Pham CVT, Ngo HQT, Le TQ, Nguyen DH.

Heart Surg Forum. 2019 Sep 24;22(5):E390-E395. doi: 10.1532/hsf.2529.

PMID:
31596718
3.

Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in HLA Sensitized Kidney Transplant Recipients.

Sethi S, Najjar R, Peng A, Choi J, Lim K, Vo A, Jordan SC, Huang E.

Transplantation. 2019 Sep 19. doi: 10.1097/TP.0000000000002976. [Epub ahead of print]

PMID:
31568398
4.

Understanding drug distribution and release in ophthalmic emulsions through quantitative evaluation of formulation-associated variables.

Dong Y, Hengst L, Hunt R, Patel D, Vo A, Choi S, Ashraf M, Cruz CN, Xu X.

J Control Release. 2019 Sep 16. pii: S0168-3659(19)30551-6. doi: 10.1016/j.jconrel.2019.09.010. [Epub ahead of print]

PMID:
31536731
5.

Rich Text Formatted EHR Narratives: A Hidden and Ignored Trove.

Zeng Z, Zhao Y, Sun M, Vo AH, Starren J, Luo Y.

Stud Health Technol Inform. 2019 Aug 21;264:472-476. doi: 10.3233/SHTI190266.

PMID:
31437968
6.

Implications of Fc Neonatal Receptor (FcRn) Manipulations for Transplant Immunotherapeutics.

Jordan SC, Ammerman N, Vo A.

Transplantation. 2019 Aug 5. doi: 10.1097/TP.0000000000002912. [Epub ahead of print]

PMID:
31397806
7.

Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients with Chronic Antibody-Mediated Rejection.

Shin BH, Everly MJ, Zhang H, Choi J, Vo A, Zhang X, Huang E, Jordan SC, Toyoda M.

Transplantation. 2019 Aug 1. doi: 10.1097/TP.0000000000002895. [Epub ahead of print]

PMID:
31385933
8.

Cancer classification and pathway discovery using non-negative matrix factorization.

Zeng Z, Vo AH, Mao C, Clare SE, Khan SA, Luo Y.

J Biomed Inform. 2019 Aug;96:103247. doi: 10.1016/j.jbi.2019.103247. Epub 2019 Jul 2.

PMID:
31271844
9.

Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant.

Redfield RR, Jordan SC, Busque S, Vincenti F, Woodle ES, Desai N, Reed EF, Tremblay S, Zachary AA, Vo AA, Formica R, Schindler T, Tran H, Looney C, Jamois C, Green C, Morimoto A, Rajwanshi R, Schroeder A, Cascino MD, Brunetta P, Borie D.

Am J Transplant. 2019 Jul 1. doi: 10.1111/ajt.15514. [Epub ahead of print]

PMID:
31257724
10.

Minimally invasive aortic valve reconstruction with autologous pericardium: how we do it.

Nguyen DH, Vo AT, Nguyen TT, Le KM, Truong BQ, Nguyen BH.

Ann Cardiothorac Surg. 2019 May;8(3):444-446. doi: 10.21037/acs.2019.05.12. No abstract available.

11.

A Cross-Sectional Study of Stress and the Perceived Style of Decision-Making in Clinicians and Patients With Cancer.

Vivian E, Oduor H, Lundberg L, Vo A, Mantry PS.

Health Serv Res Manag Epidemiol. 2019 Jun 13;6:2333392819855397. doi: 10.1177/2333392819855397. eCollection 2019 Jan-Dec.

12.

Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation System.

Sethi S, Najjar R, Peng A, Mirocha J, Vo A, Bunnapradist S, Jordan SC, Huang E.

Am J Kidney Dis. 2019 May;73(5):605-614. doi: 10.1053/j.ajkd.2018.12.036. Epub 2019 Mar 28.

PMID:
30929853
13.

Clinical Relevance of PostTransplant Donor Specific Antibodies (DSAs) in Patients Receiving Desensitization for HLA Incompatible Kidney Transplantation.

Vo AA, Aubert O, Haas M, Huang E, Zhang X, Choi J, Peng A, Najjar R, Sethi S, Ammerman N, Lim K, Jordan SC.

Transplantation. 2019 Mar 6. doi: 10.1097/TP.0000000000002691. [Epub ahead of print]

PMID:
30883456
14.

Methamphetamine-Induced Tachydysrhythmia in an Adolescent in Diabetic Ketoacidosis.

Vo A, Nguyen MB, Song JL, Cheng AL, Festekjian A.

J Emerg Med. 2019 Jun;56(6):e111-e114. doi: 10.1016/j.jemermed.2019.01.031. Epub 2019 Mar 14.

PMID:
30879847
15.

Human and Extracellular DNA Depletion for Metagenomic Analysis of Complex Clinical Infection Samples Yields Optimized Viable Microbiome Profiles.

Nelson MT, Pope CE, Marsh RL, Wolter DJ, Weiss EJ, Hager KR, Vo AT, Brittnacher MJ, Radey MC, Hayden HS, Eng A, Miller SI, Borenstein E, Hoffman LR.

Cell Rep. 2019 Feb 19;26(8):2227-2240.e5. doi: 10.1016/j.celrep.2019.01.091.

16.

Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.

Kim EY, Barefield DY, Vo AH, Gacita AM, Schuster EJ, Wyatt EJ, Davis JL, Dong B, Sun C, Page P, Dellefave-Castillo L, Demonbreun A, Zhang HF, McNally EM.

JCI Insight. 2019 Mar 21;4(6). pii: 122686. doi: 10.1172/jci.insight.122686. eCollection 2019 Mar 21.

17.

Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients.

Huang E, Sethi S, Peng A, Najjar R, Mirocha J, Haas M, Vo A, Jordan SC.

Am J Transplant. 2019 Jun;19(6):1663-1670. doi: 10.1111/ajt.15289. Epub 2019 Mar 29.

PMID:
30725531
18.

Loss of fibrinogen in zebrafish results in an asymptomatic embryonic hemostatic defect and synthetic lethality with thrombocytopenia.

Hu Z, Lavik KI, Liu Y, Vo AH, Richter CE, Di Paola J, Shavit JA.

J Thromb Haemost. 2019 Apr;17(4):607-617. doi: 10.1111/jth.14391. Epub 2019 Feb 25.

PMID:
30663848
19.

Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment.

Mackay M, Vo A, Tang CC, Small M, Anderson EW, Ploran EJ, Storbeck J, Bascetta B, Kang S, Aranow C, Sartori C, Watson P, Volpe BT, Diamond B, Eidelberg D.

JCI Insight. 2019 Jan 10;4(1). pii: 124002. doi: 10.1172/jci.insight.124002. [Epub ahead of print]

20.

Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability.

Schips TG, Vanhoutte D, Vo A, Correll RN, Brody MJ, Khalil H, Karch J, Tjondrokoesoemo A, Sargent MA, Maillet M, Ross RS, Molkentin JD.

Nat Commun. 2019 Jan 8;10(1):76. doi: 10.1038/s41467-018-08026-8.

21.

Nfe2 is dispensable for early but required for adult thrombocyte formation and function in zebrafish.

Rost MS, Shestopalov I, Liu Y, Vo AH, Richter CE, Emly SM, Barrett FG, Stachura DL, Holinstat M, Zon LI, Shavit JA.

Blood Adv. 2018 Dec 11;2(23):3418-3427. doi: 10.1182/bloodadvances.2018021865.

22.

Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity.

Niethammer M, Tang CC, Vo A, Nguyen N, Spetsieris P, Dhawan V, Ma Y, Small M, Feigin A, During MJ, Kaplitt MG, Eidelberg D.

Sci Transl Med. 2018 Nov 28;10(469). pii: eaau0713. doi: 10.1126/scitranslmed.aau0713.

PMID:
30487248
23.

Biomarkers of Parkinson's disease: Striatal sub-regional structural morphometry and diffusion MRI.

Khan AR, Hiebert NM, Vo A, Wang BT, Owen AM, Seergobin KN, MacDonald PA.

Neuroimage Clin. 2019;21:101597. doi: 10.1016/j.nicl.2018.11.007. Epub 2018 Nov 16.

24.

Minimally Invasive Ozaki Procedure in Aortic Valve Disease: The Preliminary Results.

Nguyen DH, Vo AT, Le KM, Vu TT, Nguyen TT, Vu TT, Pham CVT, Truong BQ.

Innovations (Phila). 2018 Sep/Oct;13(5):332-337. doi: 10.1097/IMI.0000000000000556.

PMID:
30394956
25.

Strengths based rehabilitation assessment: Adapted Inventory of Virtues and Strengths.

Kim JH, Keck PS, McMahon MC, Vo A, Gonzalez R, Lee DH, Barbir L, Maree K.

Work. 2018;61(3):421-435. doi: 10.3233/WOR-182807.

PMID:
30373986
26.

Selective DNAM-1 expression on small peritoneal macrophages contributes to CD4+ T cell costimulation.

Takenaka E, Van Vo A, Yamashita-Kanemaru Y, Shibuya A, Shibuya K.

Sci Rep. 2018 Oct 12;8(1):15180. doi: 10.1038/s41598-018-33437-4.

27.

Dusp6 is a genetic modifier of growth through enhanced ERK activity.

Vo AH, Swaggart KA, Woo A, Gao QQ, Demonbreun AR, Fallon KS, Quattrocelli M, Hadhazy M, Page PGT, Chen Z, Eskin A, Squire K, Nelson SF, McNally EM.

Hum Mol Genet. 2019 Jan 15;28(2):279-289. doi: 10.1093/hmg/ddy349.

PMID:
30289454
28.

Novel Therapeutic Approaches to Allosensitization and Antibody-mediated Rejection.

Jordan SC, Ammerman N, Choi J, Huang E, Peng A, Sethi S, Najjar R, Toyoda M, Lim K, Louie S, Vo A.

Transplantation. 2019 Feb;103(2):262-272. doi: 10.1097/TP.0000000000002462. Review.

PMID:
30247320
29.

Competition for synaptic building blocks shapes synaptic plasticity.

Triesch J, Vo AD, Hafner AS.

Elife. 2018 Sep 17;7. pii: e37836. doi: 10.7554/eLife.37836.

30.

Dual mechanism of microenvironmental pH modulation and foam melt extrusion to enhance performance of HPMCAS based amorphous solid dispersion.

Vo AQ, Feng X, Zhang J, Zhang F, Repka MA.

Int J Pharm. 2018 Oct 25;550(1-2):216-228. doi: 10.1016/j.ijpharm.2018.08.042. Epub 2018 Aug 21.

PMID:
30142354
31.

Longitudinal evaluation of diffusion tensor imaging and cognition in systemic lupus erythematosus.

Kozora E, Filley CM, Erkan D, Uluğ AM, Vo A, Ramon G, Burleson A, Zimmerman RD, Lockshin MD.

Lupus. 2018 Oct;27(11):1810-1818. doi: 10.1177/0961203318793215. Epub 2018 Aug 13.

PMID:
30103647
32.

Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy.

Pinelli DF, Zachary AA, Friedewald JJ, Gjertson DW, Evans MA, Chatroop EN, Leffell MS, Vo AA, Jordan SC, Montgomery RA, Tambur AR.

Am J Transplant. 2019 Feb;19(2):381-390. doi: 10.1111/ajt.15007. Epub 2018 Aug 23.

PMID:
29981209
33.

Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.

Borges VF, Ferrario C, Aucoin N, Falkson C, Khan Q, Krop I, Welch S, Conlin A, Chaves J, Bedard PL, Chamberlain M, Gray T, Vo A, Hamilton E.

JAMA Oncol. 2018 Sep 1;4(9):1214-1220. doi: 10.1001/jamaoncol.2018.1812.

34.

Application of FT-NIR Analysis for In-line and Real-Time Monitoring of Pharmaceutical Hot Melt Extrusion: a Technical Note.

Vo AQ, He H, Zhang J, Martin S, Chen R, Repka MA.

AAPS PharmSciTech. 2018 Nov;19(8):3425-3429. doi: 10.1208/s12249-018-1091-3. Epub 2018 Jun 13.

PMID:
29948985
35.

Pharmaceutical Additive Manufacturing: a Novel Tool for Complex and Personalized Drug Delivery Systems.

Zhang J, Vo AQ, Feng X, Bandari S, Repka MA.

AAPS PharmSciTech. 2018 Nov;19(8):3388-3402. doi: 10.1208/s12249-018-1097-x. Epub 2018 Jun 25.

PMID:
29943281
36.

Independent effects of age and levodopa on reversal learning in healthy volunteers.

Vo A, Seergobin KN, MacDonald PA.

Neurobiol Aging. 2018 Sep;69:129-139. doi: 10.1016/j.neurobiolaging.2018.05.014. Epub 2018 May 18.

PMID:
29894903
37.

Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study.

Murthy R, Borges VF, Conlin A, Chaves J, Chamberlain M, Gray T, Vo A, Hamilton E.

Lancet Oncol. 2018 Jul;19(7):880-888. doi: 10.1016/S1470-2045(18)30256-0. Epub 2018 May 24.

PMID:
29804905
38.

Biopharmaceutical Characterization and Oral Efficacy of a New Rapid Acting Antidepressant Ro 25-6981.

Yellepeddi VK, Zhudeva MY, Movahedi F, Vo A, Phan J, Kirsh RD, Rawlins DB, Talbot JN.

J Pharm Sci. 2018 Sep;107(9):2472-2478. doi: 10.1016/j.xphs.2018.05.005. Epub 2018 May 22.

PMID:
29800545
39.

Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers.

Wyatt EJ, Demonbreun AR, Kim EY, Puckelwartz MJ, Vo AH, Dellefave-Castillo LM, Gao QQ, Vainzof M, Pavanello RCM, Zatz M, McNally EM.

JCI Insight. 2018 May 3;3(9). pii: 99357. doi: 10.1172/jci.insight.99357.

40.

A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.

Jordan SC, Choi J, Aubert O, Haas M, Loupy A, Huang E, Peng A, Kim I, Louie S, Ammerman N, Najjar R, Puliyanda D, Vo A.

Am J Transplant. 2018 Dec;18(12):2955-2964. doi: 10.1111/ajt.14767. Epub 2018 May 14.

PMID:
29637714
41.

Acute retrograde type A intramural hematoma treated with an endovascular approach.

Vo AT, Le KM, Nguyen TT, Vu TT, Vu TT, Nguyen DH.

Asian Cardiovasc Thorac Ann. 2018 May;26(4):308-310. doi: 10.1177/0218492318766791. Epub 2018 Mar 27.

PMID:
29587524
42.

Levodopa has mood-enhancing effects in healthy elderly adults.

Vo A, Ganjavi H, MacDonald PA.

Int J Geriatr Psychiatry. 2018 Apr;33(4):674-675. doi: 10.1002/gps.4824. No abstract available.

PMID:
29498779
43.

Community service coordination for minority clients with disabilities: 10-step guidelines.

Kim JH, Barbir LA, Elder EM, Vo AK, McMahon BT, Taylor T, Johnson K.

Work. 2018;59(1):85-91. doi: 10.3233/WOR-172662.

PMID:
29439380
44.

Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.

Argyelan M, Herzallah M, Sako W, DeLucia I, Sarpal D, Vo A, Fitzpatrick T, Moustafa AA, Eidelberg D, Gluck M.

Neuroreport. 2018 May 2;29(7):532-540. doi: 10.1097/WNR.0000000000000970.

45.

Female Voiding Dysfunction and Urinary Incontinence.

Vo A, Kielb SJ.

Med Clin North Am. 2018 Mar;102(2):313-324. doi: 10.1016/j.mcna.2017.10.006. Epub 2017 Dec 20. Review.

PMID:
29406060
46.

AZA-MS: a novel multiparameter mass spectrometry method to determine the intracellular dynamics of azacitidine therapy in vivo.

Unnikrishnan A, Vo ANQ, Pickford R, Raftery MJ, Nunez AC, Verma A, Hesson LB, Pimanda JE.

Leukemia. 2018 Apr;32(4):900-910. doi: 10.1038/leu.2017.340. Epub 2017 Nov 29.

47.

Management of Intussusception in the Pediatric Emergency Department: Risk Factors for Recurrence.

Vo A, Levin TL, Taragin B, Khine H.

Pediatr Emerg Care. 2017 Dec 11. doi: 10.1097/PEC.0000000000001382. [Epub ahead of print]

PMID:
29232349
48.

Unplanned readmission following transoral robotic surgery.

Topf MC, Vo A, Tassone P, Shumrick C, Luginbuhl A, Cognetti DM, Curry JM.

Oral Oncol. 2017 Dec;75:127-132. doi: 10.1016/j.oraloncology.2017.11.009. Epub 2017 Nov 11.

PMID:
29224809
49.

Disruption of network for visual perception of natural motion in primary dystonia.

Fujita K, Sako W, Vo A, Bressman SB, Eidelberg D.

Hum Brain Mapp. 2018 Mar;39(3):1163-1174. doi: 10.1002/hbm.23907. Epub 2017 Dec 6.

50.

Medical specialty preferences in early medical school training in Canada.

Vo A, McLean L, McInnes MDF.

Int J Med Educ. 2017 Nov 14;8:400-407. doi: 10.5116/ijme.59f4.3c15.

Supplemental Content

Support Center